RVTY
NYSE
US
Revvity, Inc. Common Stock
$91.51
▼ $-1.40
(-1.50%)
Vol 100K
Mkt Cap
$10.0B
P/E
41.6
ROE
3.2%
Margin
8.5%
Beta
1.14
Div Yield
0.31%
52W
$81–$118
Wall Street Consensus
26 analysts · Apr 20265
Strong Buy
10
Buy
11
Hold
0
Sell
0
Strong Sell
57.7%
Buy Rating
Price Chart
Similar Stocks
MTD
Mettler-Toledo International Inc
P/E 31.0
$26.9B
ILMN
Illumina Inc
P/E 28.5
$20.0B
WST
West Pharmaceutical Services Inc
P/E 37.7
$18.6B
MEDP
Medpace Holdings Inc
P/E 36.5
$15.8B
TEM
Tempus AI Inc
$10.5B
TEM
Tempus AI Inc
$10.5B
TECH
Bio-Techne Corp
P/E 119.2
$9.2B
CRL
Charles River Laboratories International Inc
$8.6B
BIO
Bio Rad Laboratories Inc
P/E 9.9
$7.5B
RGEN
Repligen Corp
P/E 5307.1
$9.2B
Earnings
Beat rate: 100.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $1.58 | $1.70 | +$0.12 |
| Sep 2025 | $1.16 | $1.18 | +$0.02 |
| Jun 2025 | $1.16 | $1.18 | +$0.02 |
| Mar 2025 | $0.97 | $1.01 | +$0.04 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $729.4M | $664.8M | $720.3M | $698.9M | $772.1M |
| Net Income | — | $94.6M | $42.2M | $53.9M | $46.7M | $98.4M |
Key Ratios
ROA (TTM)
2.0%
P/S (TTM)
3.51
P/B
1.5
EPS (TTM)
$2.08
CF/Share
$5.13
Rev Growth 3Y
-4.8%
52W High
$118.30
52W Low
$81.36
$81.36
52-Week Range
$118.30
Financial Health
Free Cash Flow
$161.8M
Net Debt
$2.5B
Cash
$919.9M
Total Debt
$3.4B
As of Dec 31, 2025
How does RVTY compare to Life Sciences Tools & Services peers?
Peer group: Peers · Life Sciences Tools & Services (Peers) · 10 companies
RVTY valuation vs Life Sciences Tools & Services peers
P/E ratio
41.6
▲
14%
above
peers
(36.5)
vs Peers
vs Industry
Fair value
P/S ratio
3.5
▼
20%
below
peers
(4.4)
vs Peers
vs Industry
Pricier
P/B ratio
1.5
▼
63%
below
peers
(4.2)
vs Peers
vs Industry
Undervalued
Div yield
0.3%
▼
23%
below
peers
(0.4%)
vs Peers
vs Industry
Low yield
RVTY profitability vs Life Sciences Tools & Services peers
ROE
3.2%
▼
8%
below
peers
(3.5%)
vs Peers
vs Industry
In line
Net margin
8.5%
▲
14%
above
peers
(7.4%)
vs Peers
vs Industry
In line
Gross margin
54.8%
▲
6%
above
peers
(51.8%)
vs Peers
vs Industry
In line
ROA
2.0%
▼
20%
below
peers
(2.5%)
vs Peers
vs Industry
Below avg
RVTY financial health vs Life Sciences Tools & Services peers
D/E ratio
—
▼
0%
below
peers
(54.2)
vs Peers
vs Industry
High debt
Current ratio
1.7
▼
10%
below
peers
(1.9)
vs Peers
vs Industry
Low liquidity
Beta
1.1
▼
12%
below
peers
(1.3)
vs Peers
vs Industry
More volatile
RVTY fundamentals radar
RVTY
Peer median
Industry
RVTY profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
RVTY vs peers: key metrics
Insider Activity
BearishBuys
7
Sells
5
$4672930
GONZALES ANITA
Officer · Mar 16
award
1600 shs
GONZALES ANITA
Officer · Mar 06
award
1721 shs
VICTOR MIRIAME
Officer · Feb 24
sale
1862 shs
VICTOR MIRIAME
Officer · Feb 24
conversion of exercise of derivative security
1862 shs
MCMURRY-HEATH MICHELLE
Director · Feb 23
sale
600 shs
SINGH PRAHLAD R
Chief Executive Officer · Feb 05
sale
25525 shs
SINGH PRAHLAD R
Chief Executive Officer · Feb 05
conversion of exercise of derivative security
25525 shs
GOLDBERG JOEL S
General Counsel · Feb 05
sale
12717 shs
GOLDBERG JOEL S
General Counsel · Feb 05
conversion of exercise of derivative security
12717 shs
SINGH PRAHLAD R
Chief Executive Officer · Feb 04
award
26796 shs
Last 90 days
Top Holders
Top 5: 54.48%T. Rowe Price Investment Ma…
20.08%
$2.0B
Vanguard Group Inc
11.77%
$1.2B
Price (T.Rowe) Associates I…
7.70%
$772.8M
Edgepoint Investment Group …
7.63%
$766.4M
Janus Henderson Group PLC
7.30%
$732.8M
As of Dec 31, 2025
Dividends
$0.28
/ year
Jan 16, 2026
$0.0700
Oct 17, 2025
$0.0700
Jul 18, 2025
$0.0700
Apr 17, 2025
$0.0700
Jan 17, 2025
$0.0700
Oct 18, 2024
$0.0700
Jul 19, 2024
$0.0700
Apr 18, 2024
$0.0700